(Q83675646)

English

Efficacy, safety, and pharmacokinetics of a 10% liquid immune globulin preparation (GAMMAGARD LIQUID, 10%) administered subcutaneously in subjects with primary immunodeficiency disease

scientific article published on 22 March 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21424824%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Efficacy, safety, and pharmacokinetics of a 10% liquid immune globulin preparation (GAMMAGARD LIQUID, 10%) administered subcutaneously in subjects with primary immunodeficiency disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21424824%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

primary immunodeficiency disease

0 references

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Richard L Wasserman

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21424824%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Isaac Melamed

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21424824%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Lisa Kobrynski

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21424824%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Steven D Strausbaugh

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21424824%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Mark R Stein

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21424824%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Marlies Sharkhawy

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21424824%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Werner Engl

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21424824%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Heinz Leibl

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21424824%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Luba Sobolevsky

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21424824%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

David Gelmont

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21424824%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Richard I Schiff

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21424824%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

William J Grossman

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21424824%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

22 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21424824%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Journal of Clinical Immunology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21424824%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21424824%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21424824%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

323-331

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21424824%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

https://scigraph.springernature.com/pub.10.1007/s10875-011-9512-z

0 references

The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21424824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoglobulin treatment for primary antibody deficiencies: advantages of the subcutaneous route

1 reference

https://pubmed.ncbi.nlm.nih.gov/21424824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous immunoglobulin infusion as an alternative to intravenous immunoglobulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21424824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of a new 20% immunoglobulin preparation for subcutaneous administration, IgPro20, in patients with primary immunodeficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/21424824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21424824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health-related quality of life and treatment satisfaction in North American patients with primary immunedeficiency diseases receiving subcutaneous IgG self-infusions at home

1 reference

https://pubmed.ncbi.nlm.nih.gov/21424824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective open-label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo- or agammaglobulinemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21424824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21424824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Express subcutaneous IgG infusions: decreased time of delivery with maintained safety

1 reference

https://pubmed.ncbi.nlm.nih.gov/21424824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life and health-care resource utilization among children with primary immunodeficiency receiving home treatment with subcutaneous human immunoglobulin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21424824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21424824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy, safety and tolerability of a new 10% liquid intravenous immune globulin [IGIV 10%] in patients with primary immunodeficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/21424824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21424824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and safety of subcutaneous immune globulin (human), 10% caprylate/chromatography purified in patients with primary immunodeficiency disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21424824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Home treatment in patients with antibody deficiency by slow subcutaneous infusion of gammaglobulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21424824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid subcutaneous IgG replacement therapy is effective and safe in children and adults with primary immunodeficiencies--a prospective, multi-national study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21424824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Octagam 5%, an intravenous IgG product, is efficacious and well tolerated in subjects with primary immunodeficiency diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/21424824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of Privigen, a novel 10% liquid immunoglobulin preparation for intravenous use, in patients with primary immunodeficiencies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21424824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A history of immune globulin therapy, from the Harvard crash program to monoclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21424824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differences between IGIV products: impact on clinical outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/21424824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21424824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The product: All intravenous immunoglobulins are not equivalent

1 reference

https://pubmed.ncbi.nlm.nih.gov/21424824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21424824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83675646&oldid=2006000831"